Altamira Therapeutics prices up to $12M public offering

Altamira Therapeutics ( NASDAQ: CYTO ) announced the pricing of a public offering of 5.56M common shares accompanied by Series A-1 common warrants and Series A-2 common warrants at a combined public offering price of $0.72 per share.

The aggregate gross proceeds to the company.